• Published 2019

Instructions for use Title Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis : Text miningof the Japanese postmarketing adverse event-reporting database

@inproceedings{Andob2019InstructionsFU,
  title={Instructions for use Title Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis : Text miningof the Japanese postmarketing adverse event-reporting database},
  author={Yoshiaki Andob and Shinichi Matsudab and Shiho Tomizawab and Riwa Tanakab and Nobuhiro Takagib and Ayako Nakasoneb},
  year={2019}
}
  • Yoshiaki Andob, Shinichi Matsudab, +3 authors Ayako Nakasoneb
Objective: To search for signs and symptoms before serious infection (SI) occurs in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients. Methods: Individual case safety reports, including structured (age, sex, adverse event [AE]) and unstructured (clinical narratives) data, were analyzed by automated text mining from a Japanese post-marketing AE-reporting database (16 April 2008–10 April 2015) assuming the following: treated in Japan; TCZ RA treatment; 1 SI; unable to exclude causality… CONTINUE READING

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

American College of Rheumatology guideline for the treatment of rheumatoid arthritis

JA Singh, KG Saag, +3 authors MC Sullivan
  • Arthritis Care Res
  • 2015